free portfolio web templates

Intellectual Property

Patents for the Company’s core technologies have the potential to extend patent protection through to the late 2030s (see Table below).

Contact Us
Email mail@interk.com.au

Preclinical development of peptide based therapeutic candidates in Sydney Australia

Share this page